APA

von Beckerath N., Taubert D., Pogatsa-Murray G., Schömig E., Kastrati A. & Schömig A. (20060302). Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. : Circulation.

Chicago

von Beckerath Nicolas, Taubert Dirk, Pogatsa-Murray Gisela, Schömig Edgar, Kastrati Adnan and Schömig Albert. 20060302. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. : Circulation.

Harvard

von Beckerath N., Taubert D., Pogatsa-Murray G., Schömig E., Kastrati A. and Schömig A. (20060302). Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. : Circulation.

MLA

von Beckerath Nicolas, Taubert Dirk, Pogatsa-Murray Gisela, Schömig Edgar, Kastrati Adnan and Schömig Albert. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. : Circulation. 20060302.